BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

VisualMED Clinical Solutions Corp. First Quarter Results Meet Guidance and Expectations


11/10/2011 9:09:06 AM

RENO, NV--(Marketwire - November 10, 2011) -

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces quarterly results for the first quarter of fiscal 2012. A full disclosure statement and financial results will be available on the OTC Markets site as well as on the company website at www.visualmedsolutions.com.

Revenues were on the high side of previous guidance at $416,000 with net income of $91,264, as the Company continues to benefit from the current U.S. Administration's healthcare policies and a market place that is evolving towards the kind of products we offer. It is clear that mounting fiscal pressure will continue to push forward the modernization of clinical facilities and we expect our business to continue growing accordingly.

"We are very heartened by the progression of business, and the next quarter is going to prove quite important for us. Also we have entered into an agreement with a Swiss financial institution to secure a 15 million dollar fund strictly dedicated to provide direct vendor financing to our clients," notes VisualMED Chairman and CEO Gerard Dab. "This means we can finance client leasing and or acquisition with a faster turnaround than is currently the norm with lenders."

Being able to provide direct financing solutions to healthcare facilities should help the company secure otherwise hard to get accounts who in these uncertain times are hesitant to tap into their own credit facilities with traditional lenders.

"We had a strong quarter and are in line to achieve the same king of growth that made last year a banner year. We continue to diversify, especially bringing to market simpler and cheaper product lines," concludes Mr. Dab.

ABOUT VISUALMED
VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.


For further information, please contact:

Gerard Dab
514-582-5220



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->